WOONSOCKET – CVS Pharmacy Inc., the subsidiary of CVS Health Corp., has agreed to pay $1.5 million to resolve a federal investigation into certain stores on Long Island, N.Y., that failed to report the loss or theft of controlled substances, including the opioid hydrocodone, the U.S. Department of Justice announced Thursday.
“The failure to promptly report the loss or theft of prescription drugs as required by law contributes to the opioid epidemic, which has caused devastating harm to individuals and our community,” said Richard P. Donoghue, United States Attorney for the Eastern District of New York, in a statement. “The settlement with CVS demonstrates the resolve by this office and the [Drug Enforcement Administration, New York Division] to use all available tools to address this crisis at every level and reduce the availability of highly addictive, dangerous drugs.”
The settlement was announced by the U.S. Attorney’s Office, Eastern District of New York.
CVS Pharmacy did not respond for comment by the time of publication.
